VLA 0.00% $1.75 viralytics limited

Ann: New Data at SITC Meeting. Further Studies Announced, page-89

  1. 246 Posts.
    lightbulb Created with Sketch. 26
    I think that investors have relied on analyst reports (such as Roth & Edison) to put the trial result releases into perspective.

    It would be interesting to know why VLA has ceased funding these reports. The target SP predictions have been a joke but the analysis has been quite good.

    .
 
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.